US biotech Aura Biosciences has closed an oversubscribed ... a rare, life- and vision-threatening form of cancer with no drugs approved,” said the biotech’s CEO Elisabet de los Pinos.

Shares of Aura Biosciences AURA gained ... common primary intraocular (inside the eye) cancer in adults. Bel-Sar Leads to ...

are headaches that start in the lower part of the brain, called the brainstem. They cause symptoms such as dizziness, double vision, and lack of coordination. These changes, called an aura ...